(MENAFNEditorial)
Press Release
Financial Information
Cegedim's 8th Investor Summit:
Cegedim DNA, a Unique Presence in the Connected Healthcare Ecosystem
December 11, 2017, from 2:30 to 5:45pm CET (welcome coffee with senior Management at 2pm)
Cegedim Auditorium 17 rue de l'Ancienne Mairie in Boulogne-Billancourt
Boulogne-Billancourt, December 11, 2017
, an innovative technology and services company, will host its 8th Investor Summit on December 11th, 2017, in its Boulogne-Billancourt Auditorium. The theme is "Cegedim DNA: a Unique Presence in the Connected Healthcare Ecosystem", with a specific focus on big data, software, digital, telemedicine, connected devices, RCM[1], third party payment, and process digitization.
The meeting will be hosted by Jan Eryk Umiastowski, Cegedim Chief Investment Officer and Head of Investor Relations. It will include, for the first time, client testimonies and workshops dedicated to medical connected devices and virtual pharmacies. The agenda includes:
2015 - 2018: From business model transformation to an integrated, connected, full-service Cloud -digital suite, by Laurent Labrune, Deputy Managing Director of Cegedim. Cegedim: a unique connected healthcare ecosystem, by Jan Eryk Umiastowski. Reinventing data usage, by David Syr, Operations Manager of GERS Data. Pharmacy software, keeping pace with an evolving market, by Jérôme Matha, Managing Director of Smart Rx. Testimony by Christian-Eric Mauffré, President of CEIDO Santé pharmacists group. The digital Pharmacy, by Guy Taieb, Director of Futuramedia. Telemedicine, perspectives and strategy, by Eric Jarrousse, Vice-President of Cegedim Healthcare Software. Medical connected services and devices, by Olivier Hua, Managing Director of the Visiomed Group and CEO of BewellConnect Corp USA. Pulse and the RCM in the United States, with video testimony by Pulse's clients. Connecting healthcare professionals and patients, by Arnault Billy, Director of Docavenue.
Integrated offering combining third party payment and management, with a trusted payment processor agreement (in process), by Philippe Simon, President of Cegedim Insurance Solutions. Digitalization of company processes, including payers: case study - assisting the TOTAL group in its digital transformation, by Jan Eryk Umiastowski. HR process digitization, by Olivier Rouas, Development Manager of Cegedim SRH. Cegedim and the financial market, by Jan Eryk Umiastowski. At the meeting, Cegedim will also confirm:
Its expectation for 2017 of like-for-like revenue growth of slightly more than 6.0%, and EBITDA in a range of €66.0 million to €72.0 million inclusive. That the process of divesting its Cegelease business is ongoing and that a sale is planned in the first quarter of 2018, although there is no guarantee a sale will take place. The above outlook does not reflect the potential divestments of Cegelease and Eurofarmat. The presentation slideshow (in English), as well as the recordings (in French and English) of the meeting, will be available on Cegedim's financial website after the meeting at:
and on Cegedim IR mobile app.
To download the app, visit: http://www.cegedim.fr/finance/profil/Pages/CegedimIR.aspx
About Cegedim:
Founded in 1969, Cegedim is an innovative technology and services company in the field of digital data flow management for healthcare ecosystems and B2B, and a business software publisher for healthcare and insurance professionals. Cegedim employs more than 4,000 people in 11 countries and generated revenue of €441 million in 2016. Cegedim SA is listed in Paris (EURONEXT: CGM).
To learn more, please visit: www.cegedim.com
And follow Cegedim on Twitter: @CegedimGroup, and .
Aude Balleydier
Cegedim
Media Relations
and Communications Manager
Tel.: +33 (0)1 49 09 68 81
Jan Eryk Umiastowski
Cegedim
Chief Investment Officer
and head of Investor Relations
Tel.: +33 (0)1 49 09 33 36
Marina Rosoff
For Madis Phileo
Media Relations
Tel: +33 (0)6 71 58 00 34
Follow Cegedim:
[1] RCM : Revenue Cycle Management.
Attachments:
MENAFN1112201700703653ID1096215878
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.